Continuous versus bolus infusion of terlipressin in ovine endotoxemia

Shock

Volumn 28, Issue 5, 2007, Pages 623-629

  Lange, Matthias ^a   Morelli, Andrea ^b   Ertmer, Christian ^a   Koehler, Gabriele ^c   Bröking, Katrin ^a   Hucklenbruch, Christoph ^a   Bone, Hans Georg ^a   Van Aken, Hugo ^a   Traber, Daniel L ^d   Westphal, Martin ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Hemodynamics; Sepsis; Septic shock; Sheep; Systemic inflammatory syndrome; Vasopressin

Indexed keywords

ENDOTOXIN; SODIUM CHLORIDE; TERLIPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; HEMODYNAMICS; HYPOTENSION; LUNG VASCULAR RESISTANCE; NONHUMAN; SEPSIS; STROKE;

ANIMALS; CATECHOLAMINES; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; ENDOTOXINS; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; HYPOTENSION; LYSINE VASOPRESSIN; MYOCARDIUM; RANDOM ALLOCATION; SALMONELLA TYPHI; SHEEP; SHEEP DISEASES; TACHYPHYLAXIS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 37349095912     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/shk.0b013e318050c78d     Document Type: Article

References (35)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001.
2. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 345:588-595, 2001.
3. Taylor BS, Geller DA: Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 13:413-424, 2000.
4. Lange M, Szabo C, Van Aken H, Williams W, Traber DL, Daudel F, Broking K, Salzman AL, Bone HG, Westphal M: Short-term effects of glipizide (an adenosine triphosphate-sensitive potassium channel inhibitor) on cardiopulmonary hemodynamics and global oxygen transport in healthy and endotoxemic sheep. Shock 26:516-521, 2006.
5. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, Oz MC, Oliver JA: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95:1122-1125, 1997.
6. Villanueva C, Planella M, Aracil C, Lopez-Balaguer JM, Gonzalez B, Minana J, Balanzo J: Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose. Am J Gastroenterol 100:624-630, 2005.
7. Medel J, Boccara G, Van de Steen E, Bertrand M, Godet G, Coriat P: Terlipressin for treating intraoperative hypotension: can it unmask myocardial ischemia? Anesth Analg 93:53-55, 2001. TOC.
8. O'Brien A, Clapp L, Singer M: Terlipressin for norepinephrine-resistant septic shock. Lancet 359:1209-1210, 2002.
9. Leone M, Albanese J, Delmas A, Chaabane W, Garnier F, Martin C: Terlipressin in catecholamine-resistant septic shock patients. Shock 22:314-319, 2004.
10. Morelli A, Rocco M, Conti G, Orecchioni A, De Gaetano A, Cortese G, Coluzzi F, Vernaglione E, Pelaia P, Pietropaoli P: Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 30:597-604, 2004.
11. Albanese J, Leone M, Delmas A, Martin C: Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 33:1897-1902, 2005.
12. Scharte M, Meyer J, Van Aken H, Bone HG: Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 29:1756-1760, 2001.
13. Ioannou G, Doust J, Rockey DC: Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev: CD002147, 2001
14. Asfar P, Hauser B, Ivanyi Z, Ehrmann U, Kick J, Albicini M, Vogt J, Wachter U, Bruckner UB, Radermacher P, et al.: Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Crit Care Med 33:373-380, 2005.
15. Asfar P, Pierrot M, Veal N, Moal F, Oberti F, Croquet V, Douay O, Gallois Y, Saumet JL, Alquier P, et al.: Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 31:215-220, 2003.
16. Westphal M, Stubbe H, Sielenkamper AW, Borgulya R, Van Aken H, Ball C, Bone HG: Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 29:301-308, 2003.
17. Westphal M, Stubbe H, Sielenkamper AW, Ball C, Van Aken H, Borgulya R, Bone HG: Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep. Crit Care Med 31:1502-1508, 2003.
18. Westphal M, Sielenkamper AW, Van Aken H, Stubbe HD, Daudel F, Schepers R, Schulte S, Bone HG: Dopexamine reverses the vasopressin-associated impairment in tissue oxygen supply but decreases systemic blood pressure in ovine endotoxemia. Anesth Analg 99:878-885, 2004.
19. Traber DL: Animal models: the sheep. Crit Care Med 28:591-592, 2000.
20. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25:1279-1282, 1997.
21. Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A: High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31:2646-2650, 2003.
22. Malay MB, Ashton RC Jr, Landry DW, Townsend RN: Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 47:699-703, 1999.
23. Delmas A, Leone M, Rousseau S, Albanese J, Martin C: Clinical review: vasopressin and terlipressin in septic shock patients. Crit Care 9:212-222, 2005.
24. Moller S, Hansen EF, Becker U, Brinch K, Henriksen JH, Bendtsen F: Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver 20:51-59, 2000.
25. Westphal M, Bone HG, Van Aken H, Sielenkamper AW: Terlipressin for haemodynamic support in septic patients: a double-edged sword? Lancet 360:1250-1251, 2002. author reply 1251.
26. Westphal M, Traber DL: Low-dose terlipressin for hemodynamic support in sepsis and systemic inflammatory response syndrome: art for (he)art's sake or state of the art? Crit Care Med 33:455-457, 2005.
27. Ertmer C, Bone HG, Van Aken H, Westphal M: Terlipressin for haemodynamic support in septic shock: less may be more. Resuscitation 70:292-293, 2006.
28. Jolley DH, De Keulenaer BL, Potter A, Stephens DP: Terlipressin infusion in catecholamine-resistant shock. Anaesth Intensive Care 31:560-564, 2003.
29. Zeballos G, Lopez-Herce J, Fernandez C, Brandstrup KB, Rodriguez-Nunez A: Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock. Resuscitation 68:151-153, 2006.
30. Maybauer DM, Maybauer MO, Traber LD, Westphal M, Nakano YY, Enkhbaatar P, Morita N, Herndon DN, Traber DL: Effects of severe smoke inhalation injury and septic shock on global hemodynamics and microvascular blood flow in sheep. Shock 26:489-495, 2006.
31. Murakami K, Enkhbaatar P, Shimoda K, Cox RA, Burke AS, Hawkins HK, Traber LD, Schmalstieg FC, Salzman AL, Mabley JG, et al.: Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis. Shock 21:126-133, 2004.
32. Vincent JL: The International Sepsis Forum's frontiers in sepsis: High cardiac output should be maintained in severe sepsis. Crit Care 7:276-278, 2003.
33. Nilsson G, Lindblom P, Ohlin M, Berling R, Vernersson E: Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. Drugs Exp Clin Res 16:307-314, 1990.
34. Escorsell A, Bandi JC, Moitinho E, Feu F, Garcia-Pagan JC, Bosch J, Rodes J: Time profile of the haemodynamic effects of terlipressin in portal hypertension. J Hepatol 26:621-627, 1997.
35. Oberti F, Veal N, Kaassis M, Pilette C, Rifflet H, Trouve R, Cales P: Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats. J Hepatol 29:103-111, 1998.